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Abstract: A versatile and metal-free approach for the synthesis of carbocycles and of 
heterocycles bearing seven- and eight-membered rings is described. The strategy is based 
on ring expansion of 1-vinylcycloalkanols (or the corresponding silyl or methyl ether) 
mediated by the hypervalent iodine reagent HTIB (PhI(OH)OTs). Reaction conditions can 
be easily adjusted to give ring expansion products bearing different functional groups.  
A route to medium-ring lactones was also developed. 
Keywords: hypervalent iodine; ring expansion; rearrangement; seven-membered ring; 
antiproliferative activity 
 
1. Introduction 
The presence of seven-membered rings in compounds with remarkable biological activity continuously 
challenges organic chemists to develop efficient method for their preparation [1–14] (for examples of 
OPEN ACCESS
Molecules 2015, 20 1476 
 
 
natural or designed compounds, see Figure 1). Construction of seven-membered rings is relatively 
more difficult than the corresponding process for five- and six-membered rings, mainly because 
cyclization reactions have the inherent drawback of entropic factors and transannular  
interactions [1,3,15]. Nevertheless, a variety of different methodologies were envisioned to circumvent 
these problems, such as palladium-catalyzed intramolecular reactions, and radical and electrophilic 
cyclizations [1–4,7,9–12]. Besides the palladium-catalyzed processes, other metal-mediated reactions 
were investigated and ring-closing metathesis and cycloadditions are probably the most used in the 
synthesis of seven- and eight-membered rings [5–10,12,16]. Another approach is a ring expansion 
reaction [12,17–19], which has the main advantage to avoid entropic factors and high-diluted 
conditions [1,15]. One possible strategy to promote a ring expansion is an oxidative rearrangement that 
can be performed with transition metals, such as palladium(II) [17], mercury(II) [20], and  
thallium(III) [21,22]. An alternative to prevent the use of these metals is a hypervalent iodine reagent 
that promotes several different reactions in an efficient manner, such as formation of C–C bonds, 
stereoselective oxidations, and many important functional group transformations, including 
asymmetric reactions [23–30]. Although oxidative rearrangements mediated by hypervalent iodine 
have been reported in many publications, systematic studies regarding ring expansion reactions are 
scarce [27]. The ring expansion of methylene derivatives mediated by PhI(OH)OTs (HTIB or Koser’s 
Reagent) has been investigated by Justik and Koser for the synthesis of six-, seven-, and eight-membered 
ring carbocyclic compounds [31,32]. This protocol was subsequently applied in the total synthesis of 
both isomers of ar-himachalene (Figure 1) [33]. This article presents a versatile and metal-free 
approach for the synthesis of molecules bearing a seven-membered ring, through a ring expansion 
reaction [34]. 
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Figure 1. Compounds bearing seven-membered ring fused to aromatic ring.  
2. Results and Discussion 
The substrates required for the ring expansion reactions were prepared in an efficient manner. The 
reaction of 1-tetralone (1a) with CH2=CHMgBr gave the unsaturated 1-tetralol 2a, in 89% yield [35]. 
Considering the possible instability of the tertiary benzylic and allylic alcohol 2a, we decided to protect 
it as the trimethylsilyl (TMS) ether. The protocol using trimethylsilyl chloride/hexamethyldisilazane 
(TMSCl/HMDS) in reflux of hexane was applied to 2a, giving the desired product 3a in only 11% 
yield. However, using HMDS in the presence of a catalytic amount of I2, as reported by Karimi and 
Golshani [36], was possible to obtain cleanly 3a in 99% yield (Scheme 1). 
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Scheme 1. Preparation of the unsaturated TMS ether 3a. HMDS: hexamethyldisilazane and 
TMSCl: trimethylsilylchloride. 
The above two-step sequence was applied to several ketones, leading to 3b-l. We were also 
interested in the behavior of alkyl ethers. Thus, the methyl ether 4a was prepared treating 2a with 
KOH/MeI (Figure 2) [37]. 
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Figure 2. Structure of substrates 3b–l and 4a.  
We first performed a detailed investigation on the reactivity of the TMS-protected 1-vinylcycloalkanol 
3a. Thus, treatment of 3a with HTIB in CH3CN, in trimethylorthoformiate or without solvent [38] led 
to a complex mixture of compounds. Fortunately, when the unsaturated TMS-ether 3a was treated with 
HTIB in MeOH [31] in the presence of p-TsOH, thin layer chromatography (TLC) analysis indicated 
the cleavage of the labile TMS-group. Then, the alcohol 2a formed in the medium reacted with 
iodine(III), giving the ring expansion product 5a, in 60% yield (Table 1, Entry 1). The methoxy-ketone 5a 
would be originated from 3a in four steps. The first would be the acid-catalyzed deprotection of the 
TMS group, giving 2a, on which the electrophilic addition of iodine(III) to the double bond would give 
the cation 9. Migration of the aryl carbon would lead to 10. A reductive solvolysis on 10 would produce 
the methoxylated ketone 5a (Scheme 2). On this step occurs the highly favorable transformation of the 
hypervalent iodine into the normal valency compound PhI. Higher temperatures and longer reaction 
times promote an acid-catalyzed elimination of MeOH from 5a, furnishing the enone 6a, together with 
the dimer 7a (entry 2). TLC analysis showed that 7a is formed after the work-up. This result is slightly 
different from that using Tl(III), which gives only the enone 6a from 3a [22]. 
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Table 1. HTIB-Mediated Ring Expansion of 3a. HTIB: [Hydroxy(tosyloxy)iodo]benzene; 
p-TsOH: p-Toluenesulfonic acid. 
Entry Conditions Product (Yield) 
1 1.0 equiv HTIB, 20 mol% p-TsOH, MeOH, −72 °C to rt, 2 h 
2 1.0 equiv HTIB, MeOH, −72 to 30 °C, 2.5 h 
3 (1) 1.0 equiv HTIB, MeOH, −72 to 30 °C, 2.5 h; (2) 2 weeks 
4 2.5 equiv HTIB, MeOH, rt, 2 h 
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Scheme 2. Mechanism of the Ring Expansion of 2a. HTIB: [Hydroxy(tosyloxy)iodo]benzene. 
On standing, the mixture 6a/7a gave pure crystals of 7a, in 55% yield from 3a (Table 1, entry 3), 
whose structure was assigned by X-ray analysis [34]. The pentacyclic compound 7a is formed from the 
1-vinylcycloalkanol derivative 3a in a single operation through a tandem ring-expansion/ 
hetero-Diels-Alder reaction [39,40]. We envisioned that 7a could be used to obtain a medium ring 
lactone [41,42]. Indeed, the oxidative cleavage of the double bond of 7a could be performed with 
RuCl3/NaIO4, giving the eleven-membered ring keto-lactone 11a (Scheme 3). In summary, the 
commercially available 1-tetralone (1a) was transformed in only four steps into 11a, which bears a 
spiro seven-membered ring and a medium-ring lactone. Thus, in this short sequence of steps, the 
molecular complexity is greatly increased, because several reactions took place in a few operations. 
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Scheme 3. Preparation of the Medium-Ring Keto-Lactone 11a. 
Since the double bond of enone 6a is prone to further oxidation, we decided to investigate the 
reaction of 3a with excess of oxidant. When 3a was treated with 2.5 equiv of HTIB, a tandem ring 
expansion/addition of MeOH gave the dimethoxy-ketone 8a (Table 1, entry 4). An iodine(III)-mediated 
electrophilic addition of MeOH to the enone 6a would give 8a. In summary, different ring expansion 
products 5a–8a can be obtained from the same substrate (3a) by modification of the reaction conditions. 
After exploring the oxidation of 3a with iodine(III) under several conditions, we checked if the 
protection as a silyl ether was really required. The desired dimethoxy-ketone 8a was also obtained 
when either 2a or 4a were treated with HTIB (Scheme 4). In conclusion, the presence of the TMS 
group is not essential for the ring expansion, although higher yields of the desired product were 
observed from 3a (75%) than from 2a or from 4a (65%–67%). However, the protection of the tertiary 
benzylic and allylic alcohol 3a as a TMS ether greatly facilitate the storage of the substrate and we 
decide to do this for all substrates. 
O
MeO
8a
MeORO
2a or 4a
2.5 equiv HTIB
MeOH, rt
R=H: 67%
R=Me: 65%  
Scheme 4. Tandem Expansion/Addition of 2a and 4a by HTIB. HTIB: [Hydroxy(tosyloxy)iodo]benzene. 
A substituent in the aromatic ring can alter the migratory aptitude of the migrating carbon, which  
may influence the yield of the rearrangement product. For example, a correlation between yield of  
the product and migratory aptitude was noted by us in Tl(III)-mediated ring contraction of  
1,2-di-hydronaphthalenes [43]. Thus, we investigated the ring expansion of 3 with different groups in 
the aromatic ring. Alkyl groups in the aromatic ring can be problematic in reactions with hypervalent 
iodine [44,45]. Fortunately, the TMS-protected alcohol 3b, which bears methyl groups, gave the 
dimethoxy ketone 8b (Table 2, Entry 1) in a similar yield to the non-substituted substrate 3a. A 
methoxy group at the meta position could decrease the migratory aptitude of the migrating carbon. The 
value of the Hammett constant ρm for OMe is 0.11. Hence, a lower yield of the ring expansion product 
could be expected. However, the reaction of 3c–d with HTIB led to the corresponding ring expansion 
products 8c–d, respectively, in comparable yield (Entries 2 and 3). A methoxy group in the para 
position of the migrating carbon increases the migratory aptitude, which could accelerate the 
rearrangement. In our experience, this is usually a beneficial effect [43,46]. However, the reaction with 
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3e gave the ring expansion product 8e, in only 10% yield (entry 4). After some experimentation, we 
found that treating 3e with HTIB in a mixture of AcOEt/MeOH gave 8e, in 67% yield (Entry 5). 
Table 2. HTIB-Promoted Tandem Ring Expansion/Addition in MeOH. HTIB: 
[Hydroxy(tosyloxy)iodo]benzene; TMS: trimethylsilyl. 
Entry Substrate Products (Isolated Yield) 
1 
 
2 
 
3 
 
4 
 
5 a 3e 8e (67%) 
6 a 
 
7 b 
 
  
O
MeO
8g (65%)
MeO
Br
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Table 2. Cont. 
Entry Substrate Products (Isolated Yield) 
8 
 
 
9 
 
 
10 
 
 
11 
 
12 b 
 
a AcOEt/MeOH (2:1), −72 °C–rt; b MeOH, 0–50 °C. 
The same solvent mixture (AcOEt/MeOH) was also used in the reaction of 3f. In this case, a 
mixture of the seven-membered ring compounds 5f, 8f and 12f were isolated in very good overall yield  
(Entry 6). Compounds 5f and 8f could not be separated from each other by chromatography column or 
HPLC. The proposed mechanism for the formation of 12f was based on desaromatization reactions 
previously described in literature [47,48] (Scheme 5). The first step is the transformation of 3f into the  
seven-membered ring compound 5f, as shown in (Scheme 2), followed by the formation of the charge 
transfer complex 16 from 5f and HTIB. A single-electron-transfer (SET) oxidation of 16 yields the 
cation radical 17. Species 17 suffers a MeOH attack from the less hindered convex face and at less 
hindered carbon 4a (Figure 3), giving the radical 18. A second SET leads to carbocation 19, which 
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reacts with the solvent yielding 20. The enone 12f is formed after an acid hydrolysis of 20 catalyzed by 
acid. The relative configuration of 12f was assigned by NMR analysis, including NOESY, HMBC and 
HSQC (see Supplementary Informationfor details).  
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Scheme 5. Mechanism for the Formation of 12f. 
 
Figure 3. Structure of 17. 
The reaction of the bromo-substituted substrate 3 g with HTIB needed heating until 50 °C to furnish 
the ring expanded product in good yield (Table 2, Entry 7). As expected, a withdrawing group as 
bromide in meta position to migrating carbon decreases its aptitude to migration and, thus, more 
energetic conditions were necessary. Substrate 3h was exposure to HTIB giving 8 ha/b in 44 and 16%, 
respectively (Entry 8). The stereoselectivity is determined in the electrophilic addition of iodine(III) to 
the enone 22. This step occurs preferentially through the less hindered face (Scheme 6). 
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Scheme 6. Mechanism for the Formation of 8ha.  
The possibility of using a ring expansion reaction to prepare eight-membered rings was also 
investigated. Substrate 3i was treated with HTIB, giving the desired eight-membered ring compound 8i 
in 47% yield, together with the unsaturated ether 13i (entry 9). The relative configuration of 13i was 
assigned based on NMR data of related compounds [49]. This route can be useful to obtain  
eight-membered ring derivatives, because only three steps are necessary to obtain 8i from the 
commercially available benzosuberone. The first step in the formation of 20i (Scheme 7) is a ligand 
exchange from HTIB with 25, giving 26. A sequence of protonation of 26 and dehydration of 27 lead 
to 28, that participates in a SN2’ reaction with the solvent, yielding 20i. 
HO
-p-TsOH-TMS
I
OTs
Ph
OH
3i
O
+H+
I
OH
Ph
O
I
OH2
Ph
-H2O
O
IPh
MeOH
-H+
-PhIO
+H+
MeO
20i
25 26
27 28  
Scheme 7. Mechanism for the Formation of 20i. 
The reactivity of heterocyclic substrates was also examined. When compound 3j was treated with 
HTIB, the ring expansion reaction also took place. However, an inseparable mixture of  
seven-membered ring O-heterocycles5j, 8j, and 14j was isolated (Table 2, Entry 10). The oxygen at 
the ortho position of the migrating carbon 8j change the reactivity, as observed in other oxidative 
rearrangements promoted by iodine(III) [50]. Treatment of the sulfur derivative 3k with HTIB gave 
exclusively the sulfoxide, in 75% yield (Table 2, entry 11). The first reaction is the oxidation of the 
sulfide moiety to the corresponding sulfoxide [51]. This electron-withdrawing group would decrease 
the migratory aptitude of the migrating carbon and the SN2’ reaction became the favorable pathway. 
The reaction of substrate 3l with HTIB furnished the benzazepine 8l in good yield (Table 2, Entry 12). 
Structures like 8l are present in many natural products [52] and have different biological  
activities [53–56], being important building blocks for drugs. Among the methodologies for the 
preparation of benzazepines [57–62], metals are involved in most of them and a metal free approach 
could be a useful alternative, specially for pharmaceuticals applications. 
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The antiproliferative activity of seven-membered rings products (5f + 8f, 8d, 8g, 12f and 8l) was 
evaluated against a panel of nine human tumor cell lines and one immortalized human cell line using a 
protocol described in the literature [63,64]. This methodology aims to evaluate a group of samples in 
many different tumor cell lines to find evidence of their antiproliferative profile. In order to prioritize 
further evaluations, a threshold for mean logTGI (Total Growth Inhibition) values (mean log  
TGI ≤ 1.50) was assumed [65].  
Compounds 5f + 8f, 8g and 8l can be classified as inactive considering the average antiproliferative 
effect (mean logTGI > 1.50) (Table 3). The mixture 5f + 8f (1:1) showed a selective growth inhibitory 
effect against glioma (U251, TGI = 4.8 µg·mL−1) and prostate (PC-3, TGI = 3.6 µg·mL−1) cell lines. 
Moreover, compounds 12f and 8d showed, respectively, a moderate (mean logTGI = 1.03) and a weak 
(mean logTGI = 1.35) citostatic effects. This suggests that the presence of methoxy groups in the ring 
fused to the seven-membered system can contribute to the antiproliferative activity and the inclusion of 
a methoxy group on the carbon of the ring fusion can increase this effect. 
Table 3. Antiproliferative activities (TGI, µg·mL−1) of ring expansion products a. 
 Doxorubicin      
5f and 8f (1:1) 8d 8g 8l 12f 
U251 0.20 4.8 8.2 43.2 50.7 5.2 
UACC-62 0.86 18.1 34.4 59.3 91.3 8.4 
MCF-7 1.2 14.0 25.9 52.8 70.1 6.0 
NCI-ADR/RES 3.5 19.8 42.0 57.9 79.9 6.5 
786-0 0.27 15.9 27.6 72.8 102.4 6.7 
NCI-H460 0.61 37.2 60.3 64.6 157.7 22.9 
PC-3 0.74 3.6 8.5 44.8 88.5 10.6 
HT29 11.4 17.5 24.4 55.7 124.6 34.6 
K562 0.96 >250 25.6 >250 167.6 46.3 
HaCat 0.16 7.5 11.8 48.1 206.0 4.1 
Mean LogTGI −0.081 >1.2 1.35 >1.8 2.02 1.03 
a Tumor human cell lines: U251 (glioma); UACC-62 (melanoma); MCF-7 (breast); NCI-ADR/RES (ovarian 
resistant to multiple drugs); 786-0 (kidney); NCI-H460 (lung, non small cells); PC-3 (prostate); HT29 
(colon); K562 (leukemia). Immortalized non-tumoral cell line: HaCat (human keratinocyte).  
3. Experimental Section 
General Information  
HTIB, HMDS and MeOH were used as received. THF (tetrahydrofuran) was freshly distilled from 
sodium/benzophenone, CH2Cl2 was distilled from CaH2 and stored with molecular sieves 3 Å. Vinyl 
magnesium bromide was purchased from Aldrich or prepared from vinyl bromide and magnesium 
turnings [66]. 1-Tetralone was distilled before used (bp: ~155 °C, 32 mmHg). Column chromatography 
was performed using silica gel 200–400 Mesh. TLC analyses were performed in silica gel 60 F254 
plates, using UV, I2, p-anisaldehyde, or phosphomolybdic acid solution for visualization. 1H- and  
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13C-NMR spectra were recorded on Bruker (Billerica, MA, USA) or Varian spectrometers (Palo Alto, 
CA, USA). IR spectra were measured on a Perkin-Elmer 1750-FT (Waltham, MA, USA). Gas 
chromatography analyses were performed in a HP-6890 series II (Agilent, Santa Clara, CA, USA) 
and/or Shimadzu-2010 (Kyoto, Japan). Melting points were done in Büchi Melting Point B-545 
(Flawil, Switzerland) and are uncorrected. HRMS analyses were performed on a Bruker Daltonics 
Microtof Eletrospray (Billerica, MA, USA). CHN analyses were performed with Perkin-Elmer CHN 
2400 equipment (Waltham, MA, USA). The percentage of bromine in the organic compounds was 
determined by volumetric titration using a solution of Hg(NO3)2 and diphenylcarbazone as indicator. 
The tests with KI paper were performed applying a drop of the reaction mixture in a filter paper 
previously impregnated with a solution of KI (10%), which was dried at 100 °C. The preparation of 
compounds 3b–c and 3h–k was reported in the previous communication [34]. 
1-Tosyl-2,3-dihydroquinolin-4(1H)-one (1l). To a mixture of 1,2,3,4-tetrahydroquinoline (3.7 mL, 4.0 g, 
30 mmol) in anhydrous pyridine (15 mL), was added TsCl (7.63 g, 40.0 mmol, 1.3 equiv) at rt. The 
mixture was stirred at 60 °C for 15.5 h. The temperature was increased to 110 °C and the mixture was 
stirred for 5.5 h. The reaction mixture was cooled to −5 °C and hot H2O (25 mL) was added, 
precipitating the crude product, which was filter under reduced pressure. The solid was washed with HCl 
(0.01 mol·L−1) and H2O, and dried in the air. The small and brownish crystals (9.808 g) were 
recrystallized with MeOH (200 mL), giving colorless crystals of 1-tosyl-1,2,3,4-tetrahydroquinoline [67] 
(7.15 g, 24.9 mmol, 83%). mp: 94.6–95.2 °C (lit.[67]: 91–92 °C).To a solution of 1-tosyl-1,2,3,4-
tetrahydroquinoline (1.56 g, 5.00 mmol) in acetone (22.5 mL) at 0 °C was added anhydrous MgSO4 
(1.51 g, 12.5 mmol, 2.5 equiv) and H2O (9.0 mL). Subsequently, KMnO4 (4.35 g, 27.5 mmol, 5.5 equiv) 
was added dropwise for 30 min. The mixture was stirred for 27 h at rt. The solid was filtered under 
reduced pressure, washed with CH2Cl2 and H2O. Saturated solution of K2S2O5 (50 mL) was added to 
the resulting solution. The solid was filtered under reduced pressure. The solution was extracted with 
CH2Cl2, washed with brine, and dried with anhydrous MgSO4. The solvent was removed under 
reduced pressure, giving 1l [68], as white crystals (1.18 g, 3.93 mmol, 79%). mp 141.1–141.9 °C (lit. [69] 
141–142 °C). 
5-Methoxy-1-vinyl-1,2,3,4-tetrahydronaphthalen-1-ol (2d). General Procedure for the Preparation of 
Allylic Alcohols. To a solution of 5-methoxy-1-tetralone (3.52 g, 20.0 mmol) in anhydrous THF (20 mL) 
in a Schlenk flask, was added CH2=CHMgBr in THF (1 mol·L−1, 50.0 mL, 50.0 mmol) at 0 °C. The 
mixture was stirred for 3–4 h at rt. Saturated solution of NH4Cl (32 mL) was added dropwise at 0 °C. 
The aqueous phase extracted with AcOEt, dried under anhydrous MgSO4, filtered, and the solvent was 
removed under reduced pressure. The crude product was purified by flash column chromatography 
(hexanes/AcOEt, 4:1), giving 2d (2.97 g, 14.6 mmol, 73%), as colorless oil. IR (film) ν/cm−1 1257, 
1467, 1583, 2938, 3430; 1H-NMR (300 MHz, CDCl3) δ 1.79–1.98 (m, 5H), 2.53–2.83 (m, 2H), 3.82 (s, 
3H), 5.19 (dd, 1H, J = 1.7, 10.8), 5.29 (dd, 1H, J = 1.7, 17.1), 6.04 (dd, 1H, J = 10.8, 17.1), 6.75 (dd, 
1H, J = 0.9, 8.1), 7.00–7.03 (m, 1H), 7.17 (t, 1H, J = 8.1); 13C-NMR (75 MHz, CDCl3) δ 18.5, 23.2, 
37.3, 55.4, 73.3, 108.5, 113.1, 119.7, 126.2, 126.4, 141.0, 144.8, 156.9; LRMS m/z (%) 63 (18), 115 
(98), 128 (54), 141 (58), 155 (65), 171 (55), 186 (100); HRMS (ESI) m/z, calcd for [C13H16O2+Na]+ 
227.1048, found: 227.1039. 
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((5-Methoxy-1-vinyl-1,2,3,4-tetrahydronaphthalen-1-yl)oxy)trimethylsilane (3d). General Procedure 
for the Protection with a TMS group. A solution of 2d (2.86 g, 14.0 mmol), I2 (a crystal) in anhydrous 
CH2Cl2 (56 mL) was added dropwise for 5 min to a solution of HMDS (2.4 mL, 11 mmol) in 
anhydrous CH2Cl2 (14 mL). This mixture was stirred for 30 min at rt and Na2S2O3 (4.2 g) was added. 
The mixture became clear and was stirred for 30 min. The mixture was filtered through a silica pad  
(5 × 2 cm) using CH2Cl2 as eluent. The solvent was removed under reduced pressure and the product 
was purified by flash column chromatography (hexanes/AcOEt, 17:3), giving 3d (1.60 g, 5.79 mmol, 
41%) as a slightly yellow oil. IR (film) ν/cm−1 837, 1046, 1257, 1457, 1584, 2941; 1H-NMR (300 MHz, 
CDCl3) δ −0.04 (s, 9H), 1.70–1.85 (m, 1H), 1.87–1.99 (m, 3H), 2.56–2.78 (m, 2H), 3.81 (s, 3H), 5.05 
(dd, 1H, J = 1.8, 16.8), 5.09 (dd, 1H, J = 1.8, 10.5), 6.04 (dd, 1H, J = 10.5, 16.8), 6.71 (dd, 1H,  
J = 1.2, 7.8), 7.04 (dd, 1H, J = 1.2, 7.8), 7.13 (t, 1H, J = 7.8); 13C-NMR (75 MHz, CDCl3) δ 2.2, 18.9, 
23.0, 37.4, 55.3, 76.4, 108.1, 113.0, 120.9, 125.7, 126.1, 141.4, 145.7, 156.6; LRMS m/z (%) 73 (100), 
115 (23), 128 (17), 158 (34), 171 (17), 186 (54), 276 (M+•, 11), 248 (40); HRMS (ESI) m/z, calcd for 
[C16H24O2Si+Na]+: 299.1443, found: 299.1442. 
((6,7-Dimethoxy-1-vinyl-1,2,3,4-tetrahydronaphthalen-1-yl)oxy)trimethylsilane (3f). The general 
procedure was followed using 6,7-dimethoxy-1-tetralone (2.12 g, 10.0 mmol), THF (17 mL), and 
CH2=CHMgBr (1 M in THF, 27.2 mL, 27.2 mmol). A solution of the crude product (2.69 g) in anhydrous 
CH2Cl2 (10 mL) was added dropwise for 5 min to a solution of HMDS (1.7 mL, 8.4 mmol) and of I2 (a 
crystal) in anhydrous CH2Cl2 (40 mL). This mixture was stirred for 30 min at rt and Na2S2O3 (3.11 g) 
was added. The mixture became clear and was stirred for 30 min. The mixture was filtered through a 
silica pad (5 × 2 cm) using CH2Cl2 as eluent. The solvent was removed under reduced pressure and the 
product was purified by flash column chromatography (hexanes/AcOEt, 3:2), giving 3f, as a white 
solid (1.81 g, 5.91 mmol, 59%). mp 48.5–49.7 °C; IR (film) ν/cm−1 840, 910, 928, 1032, 1049, 1116, 
1137, 1216, 1261, 1462, 1516, 2952, 3001; 1H-NMR (300 MHz, CDCl3) δ −0.03 (s, 9H), 1.71–1.84 
(m, 1H), 1.87–1.98 (m, 3H), 2.62–2.79 (m, 2H), 3.83 (s, 3H), 3.85 (s, 3H), 5.06 (dd, 1H, J = 1.8, 16.8), 
5.09 (dd, 1H, J = 1.8, 10.5), 6.02 (dd, 1H, J = 10.5, 16.8), 6.52 (s, 1H), 6.89 (s, 1H); 13C NMR (75 MHz, 
CDCl3) δ 2.2, 19.8, 29.1, 38.0, 55.7 (2C), 76.4, 110.7, 111.5, 112.9, 129.4, 132.0, 145.8, 146.8, 148.1; 
anal. calcd for C17H26O3Si: C, 66.62; H, 8.55, found: C, 67.03; H, 8.69 (% H); LRMS m/z (%) 45 (41), 
73 (100), 115 (21), 128 (16), 188 (16), 216 (17), 179 (39), 306 (M+•, 6); HRMS (ESI) m/z, calcd for 
[C17H26O3Si+Na]+: 329.1549, found: 329.1552. 
((5-Bromo-1-vinyl-1,2,3,4-tetrahydronaphthalen-1-yl)oxy)trimethylsilane (3g). The general procedure 
was followed using 5-bromo-1-tetralone (0.788 g, 3.50 mmol), THF (25 mL), and CH2=CHMgBr (1 M 
in THF, 8.8 mL, 8.8 mmol, 2.5 equiv). The crude product was protected with a TMS group following 
the general procedure, but using HMDS (0.7 mL, 3.2 mmol) in CH2Cl2 (4 mL), and a solution of the 
crude alcohol (1.01 g) and I2 (a crystal) in CH2Cl2 (16 mL). The mixture was filtered through a silica 
pad (5 × 2 cm) using hexanes/Et2O (97:3) as eluent, giving 3g (0.783 g, 2.50 mmol, 71%), as slightly 
yellow oil. IR (film) ν/cm−1 756, 840, 900, 915, 1048, 1251, 2948; 1H-NMR (300 MHz, CDCl3) δ 
−0.02 (s, 9H), 1.77–1.86 (m, 1H), 1.89–2.01 (m, 3H), 2.67–2.82 (m, 2H), 4.99 (dd, 1H, J = 1.5, 17.1), 
5.12 (dd, 1H, J = 1.5, 10.5), 6.02 (dd, 1H, J = 10.5, 17.1), 7.03 (t, 1H, J = 7.8), 7.40 (dd, 1H, J = 1.2, 
7.8), 7.44 (dd, 1H, J = 1.2, 7.8); 13C-NMR (75 MHz, CDCl3) δ 2.2, 19.2, 30.3, 37.1, 77.2, 113.9, 
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124,9, 126.7, 128.1, 131.3, 136.4, 143.0, 145.3; anal. calcd for C15H21BrOSi: C, 55.38; H, 6.51; Br, 
24.56, found: C, 55.61; H, 6.55; Br, 24.67; LRMS m/z (%) 45 (33), 73 (100), 115 (21), 128 (21), 155 
(34), 296/298 (26), 326/324 (M+•, 6).  
1-Tosyl-4-((trimethylsilyl)oxy)-4-vinyl-1,2,3,4-tetrahydroquinoline (3l). The general procedure was 
followed using 1l (2.41 g, 8.00 mmol), THF (25 mL), and CH2=CHMgBr (1 M in THF, 20.0 mL,  
20.0 mmol, 2.5 equiv). The crude alcohol was purified by flash column chromatography (CH2Cl2 as 
eluent), giving the alcohol (0.631 g, 2.00 mmol, 25%), as yellow oil. The alcohol was protected 
following the general procedure, but using HMDS (0.34 mL, 1.6 mmol, 0.8 equiv) in CH2Cl2 (2 mL) 
and a solution of the alcohol (0.631 g, 2.00 mmol) and I2 (a crystal) in CH2Cl2 (8 mL). Compound 3l 
(0.800 g, 1.99 mmol, 100%) was obtained as brown oil. IR (film) ν/cm−1 840, 1166, 1357, 2957;  
1H-NMR (300 MHz, CDCl3) δ −0.13 (s, 9H), 1.64–1.82 (m, 2H), 2.37 (s, 3H), 3.86–4.01 (m, 2H), 4.89 
(dd, 1H, J = 1.5, 16.8), 5.00 (dd, 1H, J = 1.5, 10.5), 5.66 (dd, 1H, J = 10.5, 16.8), 7.08 (td, 1H,  
J = 1.2, 7.5, 11.7), 7.19–7.22 (m, 2H), 7.23–7.27 (m, 1H), 7.32 (dd, 1H, J = 1.8, 11.7), 7.55 (dt, 2H,  
J = 1.8, 8.4), 7.87 (dd, 1H, J = 0.9, 8.4); 13C-NMR (75 MHz, CDCl3) δ 2.2, 21.5, 35.2, 43.4, 73.8, 
114.4, 122.6, 124.1, 127.2 (2C), 128.3, 129.4, 129.6 (2C), 131.8, 136.1, 136.7, 143.7, 143.8; LRMS 
m/z (%) 45 (10), 73 (54), 91 (27), 130 (20), 156 (100), 218 (9), 246 (18), 401 (M+•, 3); HRMS (ESI) 
m/z, calcd for [C21H27NO3SSi+Na]+: 424.1379, found: 424.1376. 
1,5-Dimethoxy-5-(methoxymethyl)-5,7,8,9-tetrahydro-6H-benzo[7]annulen-6-one (8d). General 
Procedure for the Ring Expansion of TMS-protected Allylic Alcohols. To a solution of 3d (0.138 g, 
0.500 mmol) in MeOH (2 mL) was added HTIB (0.490 g, 1.25 mmol) at 0 °C. The progress of the 
reaction was monitored by filter paper impregnated with a solution of KI (10%). The reaction was 
stirred for 1 h at this temperature and 1 h at rt. The reaction was quenched with saturated solution of 
NaHCO3 (3 mL). The aqueous phase was extracted with CH2Cl2 (3 × 5 mL). The organic phase was 
washed with H2O and with brine. The organic phase was dried with anhydrous MgSO4, filtered and the 
solvent was removed under reduced pressure. The residue was purified by flash column 
chromatography (hexanes/Et2O, 2:3), giving 8d (0.0676 g, 0.256 mmol, 51%), as yellow oil. IR (film) 
ν/cm−1 1079, 1098, 1469, 1581, 1718, 2834, 2935; 1H-NMR (300 MHz, CDCl3) δ 1.67–1.82 (m, 1H), 
2.06–2.18 (m, 1H), 2.40–2.47 (m, 1H), 2.96 (dtd, 1H, J = 3.3, 13.2), 3.19 (s, 3H), 3.34–3.20 (m, 2H), 
3.39 (s, 3H), 3.81 (s, 3H), 3.98 (d, 1H, J = 9.6), 4.21 (d, 1H, J = 9.6), 6.83–6.89 (m, 2H), 7.19 (t, 1H,  
J = 8.1); 13C-NMR (75 MHz, CDCl3) δ 21.6, 27.5, 39.5, 51.2, 55.9, 59.7, 72.4, 87.6, 111.3, 119.3, 
127.0, 129.9, 136.2, 157.0, 210.1; LRMS m/z (%) 45 (56), 77 (22), 91 (29), 115 (25), 144 (41), 159 
(61), 172 (37), 191 (100), 219 (36), 264 (M+•, 5); HRMS (ESI) m/z, calcd for [C15H20O4+Na]+: 
287.1259, found: 287.1258. 
Oxidation of 3f with HTIB. The general procedure for ring expansion was followed, using HTIB  
(0.490 g, 1.25 mmol), solution of 3f (0.153 g, 0.500 mmol) and of PTSA (0.020 g, 0.12 mmol, 20 mol %) 
in AcOEt/MeOH (2:1, 3 mL) at −72 °C. The residue was purified by flash column chromatography 
(hexanes/AcOEt, 3:7), giving a mixture of 5f and 8f (0.100 g, 0.424 mmol, 76%), as yellow oil and 12f 
(0.015 g, 0.054 mmol, 10%), as white solid. 2,3-Dimethoxy-5-(methoxymethyl)-5,7,8,9-tetrahydro-
6H-benzo[7]annulen-6-one (5f): 1H-NMR (500 MHz, CDCl3) δ 1.88–1.95 (m, 1H), 2.05–2.11 (m, 1H), 
Molecules 2015, 20 1488 
 
 
2.54–2.58 (m, 1H), 2.67–2.72 (m, 1H), 2.84–2.94 (m, 2H), 3.38 (s, 3H), 3.83 (dd, 1H, J = 6.0, 9.0), 
3.87 (d, 6H, J = 2.0), 4.00–4.02 (m, 1H), 4.12 (dd, 1H, J = 7.5, 9.0), 6.64 (s, 1H), 6.71 (s, 1H);  
13C-NMR (125 MHz, CDCl3) δ 28.0, 32.6, 43.5, 55.9, 56.1, 56.6, 59.2, 71.2, 111.5, 113.1, 126.6, 
133.0, 147.6, 147.8, 209.3; HRMS (ESI) m/z, calcd for [C15H20O4+Na]+: 287.1259, found: 287.1259. 
2,3,5-Trimethoxy-5-(methoxymethyl)-5,7,8,9-tetrahydro-6H-benzo[7]annulen-6-one (8f): 1H-NMR 
(500 Hz, CDCl3) δ 1.80–1.87 (m, 1H), 2.12–2.19 (m, 1H), 2.44 (quin, 1H, J = 5.5), 2.63 (ddd, 1H, J = 3.5, 
6.5, 14.0), 3.19 (s, 3H), 3.24–3.32 (m, 2H), 3.42 (s, 3H), 3.88 (d, 6H, J = 2.0), 3.98 (d, 1H, J = 10.0), 4.20 
(d, 1H, J = 9.5), 6.62 (s, 1H), 6.67 (s, 1H); 13C-NMR (125 MHz, CDCl3) δ 28.9, 33.2, 39.4, 51.0, 55.8, 
56.1, 59.7, 72.1, 87.5, 110.8, 114.2, 126.3, 134.5, 147.3, 148.6, 209.9; HRMS (ESI) m/z, calcd for 
[C16H22O5+Na]+: 317.1365, found: 317.1364. trans-3,4a-Dimethoxy-9-(methoxymethyl)-4a,5,6,7-
tetrahydro-2H-benzo[7]annulene-2,8(9H)-dione (12f): mp 160.4–161.0 °C; IR (film) ν/cm−1 1091, 
1170, 1227, 1392, 1451, 1669, 1700, 2937; 1H-NMR (300 MHz, CDCl3) δ 1.46–1.55 (m, 1H), 1.67–1.76 
(m, 1H), 2.30–2.60 (m, 4H), 3.62 (dd, 1H, J = 7.2, 9.6), 3.71 (s, 3H), 3.98 (dd, 1H, J = 6.6, 9.6), 4.34 (t, 
1H, J = 6.9), 5.64 (s, 1H), 6.23 (d, 1H, J = 0.9); 13C-NMR (75 MHz, CDCl3) δ 17.8, 42.6, 42.9, 50.9, 
52.6, 55.1, 59.2, 69.9, 77.4, 118.7, 128.6, 151.7, 158.0, 180.1, 205.1; LRMS m/z (%) 39 (49), 51 (76), 
65 (44), 77 (84), 91 (100), 103 (42), 115 (57), 131 (42), 149 (51), 161 (54), 177 (65), 192 (40), 205 (60), 
220 (96), 233 (26), 248 (43); HRMS (ESI) m/z, calcd for [C15H20O5+Na]+: 303.1208, found: 303.1207. 
1-Bromo-5-methoxy-5-(methoxymethyl)-5,7,8,9-tetrahydro-6H-benzo[7]annulen-6-one (8g). To a solution 
of 3g (0.193 g, 0.481 mmol) and of PTSA (0.020 g, 0.12 mmol, 24 mol %) in MeOH (3 mL) was 
added HTIB (0.471 g, 1.20 mmol) at 0 °C. The mixture was stirred for 1 h. The temperature was 
increased to rt and the mixture was stirred for 2 h. The temperature was increased to 50 °C and the 
mixture was stirred for 3 h. The reaction was quenched with saturated solution of NaHCO3 (5 mL). 
The aqueous phase was extracted with CH2Cl2 (3 × 5 mL). The organic phase was washed with H2O 
and with brine. The organic phase was dried with anhydrous MgSO4, filtered and the solvent was 
removed under reduced pressure. The residue was purified by flash column chromatography 
(hexanes/AcOEt, 9:1), giving 8g (0.102 g, 0.325 mmol, 65%), as slightly yellow oil. IR (film) ν/cm−1 
744, 790, 1119, 1437, 1719, 2828, 2932; 1H-NMR (300 MHz, CDCl3) δ 1.78–2.14 (m, 2H), 2.38–2.48 
(m, 1H), 2.99–3.14 (m, 1H), 3.21 (s, 3H), 3.24–3.30 (m, 2H), 3.35 (s, 3H), 3.93 (d, 1H, J = 9.6), 4.12 
(d, 1H, J = 9.9), 7.11 (t, 1H, J = 7.8), 7.31 (dd, 1H, J = 1.2, 7.8), 7.57 (dd, 1H, J = 1.2, 7.8);13C-NMR 
(75 MHz, CDCl3) δ 26.0, 30.1, 38.6, 51.6, 59.7, 72.3, 86.5, 125.9, 126.9, 127.7, 133.4, 137.7, 139.4, 
209.1. LRMS m/z (%) 45 (62), 89 (18), 115 (34), 128 (100), 209 (16), 220 (17), 239/241 (33), 267/269 
(21), 312/314 (M+•, 5); HRMS (ESI) m/z, calcd for [C14H1779BrO3+Na]+: 335.0259, found: 335.0261, 
calcd for [C14H1781BrO3+Na]+: 337.0238, found: 337.0230. 
5-Methoxy-5-(methoxymethyl)-1-tosyl-1,2,3,5-tetrahydro-4H-benzo[b]azepin-4-one (8l). The reaction 
was performed as described for 8g, using a solution of 3l (0.197 g, 0.490 mmol) and of PTSA (0.020 g, 
0.12 mmol, 24 mol %) in MeOH (3 mL), and HTIB (0.481 g, 1.23 mmol). The residue was purified by 
flash column chromatography (hexanos/AcOEt/CH2Cl2, 5:1:4), giving 8l (0.135 g, 0.346 mmol, 69%), as 
slightly yellow solid.mp 100.4–100.7 °C; IR (film) ν/cm−1 1159, 1348, 1454, 1487, 1720, 2827, 2930; 
1H-NMR (300 MHz, CDCl3) δ 2.45 (s, 3H), 2.51–2.58 (m, 1H), 3.06–3.14 (m, 1H), 3.23 (s, 3H), 3.31 
(s, 3H), 3.73 (d, 1H, J = 10.8), 3.83 (bs, 2H), 4.19 (d, 1H, J = 10.5), 7.29–7.38 (m, 5H), 7.55–7.57 (m, 
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1H), 7.77 (dt, 2H, J = 1.8, 3.9, 8.4); 13C-NMR (75 MHz, CDCl3) δ 21.6, 38.8, 48.6, 52.5, 59.6, 72.5, 
85.4, 127.5, 127.7 (2C), 128.1, 129.3, 129.5, 129.8 (2C), 137.3 (2C), 144.0 (2C), 205.4; LRMS m/z 
(%) 45 (100), 65 (52), 77 (27), 91 (87), 130 (33), 389 (M+•, 1); HRMS (ESI) m/z, calcd for 
[C20H23NO5S+Na]+: 412.1195, found: 412.1182. 
The compounds 5f + 8f (1:1), 8d, 8g, 12, 15 and 22l were evaluated in vitro against a panel of nine 
cell lines [U251 (glioma); UACC-62 (melanoma); MCF-7 (breast); NCI-ADR/RES (ovarian resistant 
to multiple drugs); 786–0 (kidney); NCI-H460 (lung, non small cells); PC-3 (prostate); HT29 (colon); 
K562 (leukemia)] kindly provided by Frederick MA (National Cancer Institute, Bethesda, MD, USA) and 
the immortalized human keratinocytes (HaCat) cell line kindly provided by Prof. Dr. Ricardo Della Coletta 
(University of Campinas, UNICAMP, Campinas, Brazil). Stock and experimental cultures were grown 
in medium containing 5 mL RPMI 1640 (GIBCO BRL) supplemented with 5% fetal bovine serum 
(GIBCO BRL). Penicilin/Streptomicin mixture (1000 Um·L−1:1000 μg·mL−1, 1 mL L−1 RPMI) was added 
to the experimental cultures. Cells in 96-well plates (100 μL cells well−1) were exposed to sample 
concentrations in DMSO/RPMI (0.25, 2.5, 25, 250 μg·mL−1) in triplicate at 37 °C, 5% of CO2 in air for 
48 h. The final DMSO concentration did not affect cell viability. Doxorubicin (0.025 to 25 µg·mL−1) 
was used as positive control. Before (T0 plate) and after the sample addition (T1 plates), cells were 
fixed with 50% trichloroacetic acid, and cell proliferation was determined by spectrophotometric 
quantification (540 nm) of cellular protein using the sulforhodamine B assay. Using the dose-response 
curve for each cell line, the concentration that totally inhibits cell growth (TGI, expressed in µM) was 
determined through non-linear regression analysis using ORIGIN software version 8.0 (OriginLab 
Corporation, Northampton, MA, USA, 2007) [63,70]. 
4. Conclusions 
In conclusion, a metal-free approach for the synthesis of seven- and eight- membered rings through 
an iodine(III)-mediated ring expansion reaction was described. The substrates can be easily obtained 
from readily available starting materials. The amount of the oxidizer and the reaction conditions can be 
managed to obtain different products. Moreover, a short route to the synthesis of medium-ring lactones 
was developed. The antiproliferative activity of new seven-membered ring compounds was evaluated, 
and the results showed compound 12f as having a moderated citostatic effect. The results herein 
described have great potential for application in the chemical synthesis of seven-membered rings. 
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